Bedaquiline Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
Condition:   Tuberculosis, Multidrug-Resistant Interventions:   Drug: Bedaquiline;   Drug: Levofloxacin;   Drug: Linezolid;   Drug: Cycloserine;   Drug: Clofazimine;   Drug: Pyrazinamide;   Drug: Protionamide Sponsor:   Beijing Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2022 Category: Research Source Type: clinical trials

Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
Condition:   Pulmonary TB Interventions:   Drug: Delamanid + Bedaquiline + OPC-167832 10 mg;   Drug: Delamanid + Bedaquiline + OPC-167832 30 mg;   Drug: Delamanid + Bedaquiline + OPC-167832 90 mg;   Drug: RHEZ Sponsors:   Otsuka Pharmaceutical Development& Commercialization, Inc.;   Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 3, 2022 Category: Research Source Type: clinical trials